user

CD44 expression is associated with unfavorable prognosis in esophageal cancer patients undergoing neoadjuvant chemoradiotherapy

被引：0
|
作者：
Yoshikawa, Reigetsu [1 ]
Tsujimura, Tohru [1 ]
Tao, Lihua [1 ]
Kaibe, Nobuaki [1 ]
Sasako, Mitsuru [1 ]
Fujiwara, Yoshinori [1 ]
机构：
[1] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1634
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy
    Honing, Judith
    Pavlov, Kirill V.
    Mul, Veronique E. M.
    Karrenbeld, Arend
    Meijer, Coby
    Faiz, Zohra
    Smit, Justin K.
    Hospers, Geke A. P.
    Burgerhof, Johannes G. M.
    Kruyt, Frank A. E.
    Kleibeuker, Jan H.
    Plukker, John T. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) : 152 - 158
  • [2] CD44, a cancer stemness marker, to predict poor clinical outcome of esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Fujiwara, Yoshinori
    Yoshikawa, Reigetsu
    Tsujie, Masanori
    Kato, Hiroaki
    Takeyama, Hiroshi
    Kitani, Kotaro
    Yukawa, Masao
    Inoue, Masatoshi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Esophageal cancer: improved prognosis with neoadjuvant chemoradiotherapy
    Knippen, Stefan
    Duma, Marciana-Nona
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (01) : 86 - 88
  • [4] CD44 variant isoform expression and breast cancer prognosis
    Tokue, Y
    Matsumura, Y
    Katsumata, N
    Watanabe, T
    Tarin, D
    Kakizoe, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (03): : 283 - 290
  • [5] CD44 variant 6 (CD44v6) expression is associated with poor prognosis in superficial esophageal adenocarcinoma (SADC).
    Ormsby, AH
    Rice, TW
    Rybicki, LA
    Goldblum, JR
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A659 - A659
  • [6] Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer
    Fang, Yu-Jing
    Zhang, Lin
    Wu, Xiao-Jun
    Lu, Zhen-Hai
    Li, Ji-Bin
    Ou, Qing-Jian
    Zhang, Mei-Fang
    Ding, Pei-Rong
    Pan, Zhi-Zhong
    Wan, De-Sen
    [J]. TUMOR BIOLOGY, 2012, 33 (06) : 1907 - 1914
  • [7] Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
    Honing, Judith
    Pavlov, Kirill V.
    Meijer, Coby
    Smit, Justin K.
    Boersma-van Ek, Wytske
    Karrenbeld, Arend
    Burgerhof, Johannes G. M.
    Kruyt, Frank A. E.
    Plukker, John Th M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S657 - S664
  • [8] Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma
    Jung, Woon Yong
    Kang, Youngran
    Lee, Hyunjoo
    Mok, Young-Jae
    Kim, Han Kyeom
    Kim, Aeree
    Kim, Baek-hui
    [J]. HISTOPATHOLOGY, 2013, 63 (04) : 474 - 481
  • [9] Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
    Judith Honing
    Kirill V. Pavlov
    Coby Meijer
    Justin K. Smit
    Wytske Boersma-van Ek
    Arend Karrenbeld
    Johannes G. M. Burgerhof
    Frank A. E. Kruyt
    John Th. M. Plukker
    [J]. Annals of Surgical Oncology, 2014, 21 : 657 - 664
  • [10] PREDICTIVE VALUE OF CD24 AND CD44 FOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN PATIENTS WITH PRIMARY BREAST CANCER
    Horiguchi, K.
    Toi, M.
    Horiguchi, S.
    Sugimoto, M.
    Naito, Y.
    Hayashi, Y.
    Ueno, T.
    Ohno, S.
    Sekine, S.
    Kitagawa, D.
    Aruga, T.
    Suzuki, E.
    Yamashita, T.
    Funata, N.
    Tomita, M.
    Eishi, Y.
    Kuroi, K.
    [J]. EJC SUPPLEMENTS, 2011, 9 (01): : 4 - 4
12345